FindTrial
Sign In

Antithrombotic Treatment in patients with Effectively Maintained Sinus rhythm after Atrial Fibrillation ablation

Antithrombotic Treatment in patients with Effectively Maintained Sinus rhythm after Atrial Fibrillation ablation

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000535
Enrollment
750
Registered
2012-09-13
Start date
2017-02-24
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : we want to compare the safety and procedural complication between two groups. 1) Intervention group with antiplatelet (aspirin 100mg q d or clopidogrel 75mg q d) 2) Intervention group with anti

Sponsors

Koera University Guro Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Atrial fibrillation patients with normal sinus rhythm for 6 months after radiofrequency catheter ablation ? the patients that agree on the informed consents for this study ? age of > 19 years old

Exclusion criteria

Exclusion criteria: ? patients with atrial fibrillation recurrences after Radiofrequency catheter ablation ? patients with valvular heart disease ? patients with hypertrophic cardiomyopathy ? patienst with history of stroke

Design outcomes

Primary

MeasureTime frame
Atrial fibrillation recurrence—

Secondary

MeasureTime frame
bleeding & thrombosis complication and clinical manifestation according to medication.—

Countries

Korea, Republic of

Contacts

Public ContactHong Euy Lim

Koera University Guro Hospital

hongeuy1046@gmail.com+82-2-2626-1046

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026